The Danish company Novo Nordisk sells several different brand names with semaglutide as an active ingredient: notably, Ozempic, for diabetes and reducing cardiovascular event risks, and Wegovy, for weight loss and reducing cardiovascular event risks
No significant changes in lab tests (e.g., blood counts, liver/kidney function) have been observed
Why Pre-Treatment Testing for Semaglutide Matters Specific blood tests can uncover any hidden conditions that might impact how well the treatment works or whether it poses health risks
The molecular structure of Semaglutide allows it to bind more strongly to GLP-1 receptors, creating a more potent effect on blood sugar regulation and weight management
Hormonal patterns behind weight gain Hormonal weight gain linked to stress, aging or life transitions changes how hunger and fat storage are regulated